Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study.

Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study.

Podrobná bibliografie
Hlavní autoři:	Mitchell, SA, Thyssen, M, Mitchell, M, Orchard, T, Jewell, D, Fleming, K, Chapman, R
Médium:	Journal article
Vydáno:	1998

Podobné jednotky

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.
Autor: Mitchell, SA, a další
Vydáno: (2002)

Cytokine profiles in primary sclerosing cholangitis (PSC) and autoimmune liver diseases: Comparing expression in the periphery and the liver.
Autor: Mitchell, SA, a další
Vydáno: (1997)

Primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (2000)

Enhanced cytokine mRNA expression in Primary Sclerosing Cholangitis (PSC) and autoimmune liver diseases.
Autor: Mitchell, S, a další
Vydáno: (1997)

ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
Autor: Bloom, S, a další
Vydáno: (1992)

The management of primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (1998)

TISSUE DISTRIBUTION OF AN AUTOANTIGEN SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
Autor: Lo, S, a další
Vydáno: (1992)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
Autor: Shanahan, J, a další
Vydáno: (1998)

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
Autor: Mehal, W, a další
Vydáno: (1993)

Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
Autor: Mitchell, SA, a další
Vydáno: (1997)

Role of interleukin-10 in the pathogenesis of primary sclerosing cholangitis and primary biliary cirrhosis?
Autor: Mitchell, SA, a další
Vydáno: (1998)

Review article: the management of primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (1997)

New time dependent prognostic models for primary sclerosing cholangitis (PSC)
Autor: Rocca, G, a další
Vydáno: (2000)

INAPPROPRIATE EXPRESSION OF BLOOD-GROUP ANTIGENS ON THE BILIARY EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
Autor: Bloom, S, a další
Vydáno: (1990)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
Autor: Chapman, R
Vydáno: (2010)

Primary sclerosing cholangitis--an immunologically mediated disease?
Autor: Chapman, R, a další
Vydáno: (1985)

Liver cell proliferation in primary sclerosing cholangitis (PSC), as assessed by anti-KI-67 labelling.
Autor: Shanahan, J, a další
Vydáno: (1998)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
Autor: Snook, J, a další
Vydáno: (1987)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
Autor: Lo, S, a další
Vydáno: (1991)

Primary sclerosing cholangitis
Autor: Chapman, R
Vydáno: (2007)

Primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1985)

Primary sclerosing cholangitis.
Autor: Cullen, S, a další
Vydáno: (2003)

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
Autor: Mitchell, SA, a další
Vydáno: (1997)

A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension.
Autor: Satsangi, J, a další
Vydáno: (2000)

Primary sclerosing cholangitis.
Autor: Williamson, K, a další
Vydáno: (2014)

Primary sclerosing cholangitis.
Autor: Worthington, J, a další
Vydáno: (2006)

Primary sclerosing cholangitis
Autor: Chapman Roger, a další
Vydáno: (2006-10-01)

Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: A role for IL10 in the pathogenesis?
Autor: Mitchell, SA, a další
Vydáno: (1997)

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
Autor: Mitchell, SA, a další
Vydáno: (2001)

Characterization of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis (PSC) ulcerative colitis (UC).
Autor: Cameron, B, a další
Vydáno: (1998)

OLIGONUCLEOTIDE DNA TYPING ANALYSIS OF THE HLA DRB3 LOCUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)
Autor: Mehal, W, a další
Vydáno: (1991)

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
Autor: Snook, J, a další
Vydáno: (1988)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
Autor: Martins, E, a další
Vydáno: (1995)

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?
Autor: Mitchell, SA, a další
Vydáno: (1998)

The management of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (2003)

The immunology of primary sclerosing cholangitis.
Autor: Chapman, R
Vydáno: (1990)

Primary sclerosing cholangitis - Foreword
Autor: Chapman, R
Vydáno: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
Autor: Chapman, R
Vydáno: (1993)

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
Autor: Snook, J, a další
Vydáno: (1989)

Tissue distribution of autoantigen specific for primary sclerosing cholangitis.
Autor: Lo, S, a další
Vydáno: (1993)